FUSE Health alternatives worth evaluating include TEHR, Cuvo, Tessic, Lithos, Beluga, CareValidate, MD Integrations and Healthie, depending on the work you want a partner to perform. TEHR publishes this page and places itself first; the order is editorial, not independent testing, a market-wide verdict or a scored ranking.

How should you build this shortlist?

If you searched for an alternative because of a percentage-based charge, do not stop at finding a vendor with a different fee label. Determine the full fee base, the events that trigger charges and the other services you must pay for. A lower platform bill can coexist with more internal work or separate clinical and fulfillment expenses.

If the concern is implementation, write down which tasks you can perform: storefront configuration, integration maintenance, subscription operations and patient support. Then compare a managed package with the cost of doing those tasks yourself. The white-label infrastructure guide helps define the layers. This shortlist uses different operating models deliberately; the objective is to find a suitable responsibility boundary rather than claim every alternative is interchangeable.

Which alternative fits which buying question?

The following are evaluation routes, not claims that one vendor is universally best. Public-source review date: October 22, 2026. Confirm the current written scope before contracting.

PlatformReason to evaluateQuestion to resolve
TEHRFlat-fee brand operating modelWhich transactions and services are covered?
Cuvo HealthPublished managed packagesWhat setup work is included?
Tessic HealthTiered recurring platformWhich tier matches your needs?
Lithos HealthCustomer-owned product integrationCan your team operate the interface?
Beluga HealthFlexible clinical connectionWhich commerce components stay?
CareValidateManaged support coordinationHow are services priced and owned?
MD IntegrationsClinical integration choiceDoes the program fit its scope?
HealthiePractice softwareWho supplies the remaining operation?

When is TEHR the right FUSE alternative?

TEHR uses a flat platform subscription and flat transaction fee with 0% revenue share. That is a useful structure to evaluate when your concern is the relationship between order value and platform charges. Request a scoped quote and the definition of a billable transaction before concluding that it is cheaper for your business.

TEHR also combines brand software, payments, subscriptions and administrative coordination with independent clinical services. Its strength to test is whether those components reduce the work your team needs to assemble. Ask for a demonstration of renewals, refunds, unresolved orders and support routing. The tradeoff is that the actual service scope must be confirmed rather than inferred from a turnkey label. Review the platform alongside the commercial schedule.

When should you evaluate Cuvo’s managed packages?

Cuvo’s pricing page presents setup and recurring packages and an included migration offer. It is relevant if you want a more explicitly packaged implementation rather than deciding how much of the initial build to perform yourself.

Ask which deliverables arrive with the chosen tier, how revisions are handled and whether your current website needs replacement. A setup fee is not necessarily wasteful if it buys work you would otherwise procure, but it should correspond to an acceptance checklist. The strength is a concrete package structure; the tradeoff is upfront commitment and plan-specific scope. Compare the complete year-one cost with your expected workload, and use the Cuvo comparison for the detailed commercial questions.

When does Tessic provide a useful comparison?

Tessic publishes a tiered managed-platform offer with separate setup and consultation charges. Evaluate it when you want to compare the cost of an operated brand package rather than only a self-service design environment.

The practical question is which tier includes the workflows you intend to run. List automation, integration, multibrand and security requirements, then ask the team to map them to the proposal. The strength is visible plan structure; the tradeoff is that a lower entry price may not represent your required configuration. Keep medication, processing and other operating costs outside the platform subtotal until the quote shows how they are charged. Do not assume a subscription replaces every service needed to run care.

When does Lithos fit a product-led team?

Lithos positions a clinical practice behind the customer’s product. It is worth evaluating if your team wants to preserve an application or build its own patient experience while changing the clinical infrastructure underneath.

The strength is separation between your product and the clinical service. The tradeoff is responsibility for the software and operational connections you retain. Ask who handles an encounter status that fails to update, a patient message that needs escalation or an order event that arrives twice. Compare live implementation work rather than the ease of accessing a sandbox. A developer-friendly route can be appropriate, but it should not be purchased as though it automatically includes a finished customer-support and commerce operation.

When should you choose a Beluga integration route?

Beluga describes more than one way to connect clinical services, including hosted intake and direct integration. Consider it when your existing commerce experience is working and the priority is changing how care is connected to it.

Ask which components remain yours, which Beluga supplies and which come through a platform partner. This matters for pricing, incident ownership and future changes. The strength is architectural choice; the tradeoff is that a modular arrangement can leave more coordination with your team. Require an end-to-end demonstration in the exact route you plan to buy. A general platform demo may show functionality that belongs to a different integration path or another commercial arrangement.

When does CareValidate address a service gap?

CareValidate describes managed support and clinical operations within its launch offering. It deserves evaluation if your interest in leaving FUSE is less about building tools and more about the service workload after launch.

Bring a real operational case: a customer asks about a delayed order, a patient needs a clinical response and a payment question arrives in the same thread. Ask who separates and resolves those tasks. The strength to test is coordinated service delivery; the tradeoff is that public numerical fees were not established in this review. Obtain a proposal that names support hours, escalation owners, excluded tasks and charges. Do not turn a missing public price into a judgment about value before seeing the scope.

When does MD Integrations match the clinical requirement?

MD Integrations offers API and ready-made white-label routes. Evaluate it when a clinical integration is the missing layer and your business is prepared to own other commercial systems.

Its FAQ excludes controlled-substance prescribing, so check intended programs early rather than relying on a broad category label. The strength is choice in how the clinical service connects to your experience; the tradeoff is the retained work around that connection. Ask how patient questions, repeat visits and fulfillment information reach your staff. Request tailored commercial terms and implementation scope. If your team needs an entire operated brand environment, make sure the proposal accounts for that broader requirement instead of comparing only clinical encounter cost.

When should practice software enter the shortlist?

Healthie’s Enterprise white-label option is a software route. It may fit an organization with its own clinical team or separately arranged clinical relationships that primarily needs a branded practice-management experience.

The strength is the ability to evaluate software around an established care operation. The tradeoff is that software pricing is not the cost of supplying independent clinicians, pharmacy services and every administrative function. Ask what branding applies across the web experience and where third-party interfaces remain. Compare the full operating architecture, not an entry software subscription against a managed health-brand proposal. This route is particularly different from choosing a partner to supply the clinical and operational layers you do not yet have.

How should you test the economics before switching?

Use the same transaction examples for every proposal: an initial order, a renewal, a discount, a partial refund and a cancellation. Ask the vendor to show each platform and processing charge, including when a fee is not returned. The calculation should be reproducible by your finance team, not dependent on a verbal explanation in a sales call.

FUSE’s own pricing page distinguishes its merchant service fee from potential separate clinical, pharmacy and processing costs and contains conflicting DIY monthly figures. Preserve that uncertainty until a written quote resolves it. For an existing business, combine the cost exercise with migration planning. Do not move patient records, subscriptions or active care simply because a new storefront looks ready. Test the retained website, clinical handoffs and recurring payments before expanding the cutover.

How should a free build trial be evaluated?

Use a build trial to answer a specific product question, such as whether your intended checkout and patient navigation can be represented accurately. Record which screens use demonstration data and which require live-service configuration. Then ask for the work remaining between the preview and a patient-ready operation. This prevents a useful trial from being mistaken for completed onboarding and helps you compare it fairly with a managed implementation proposal.

What is the next useful step?

Compare two or three written scopes against the operating brief you developed. Use TEHR vs FUSE Health for the direct comparison, TEHR pricing for the commercial structure and a TEHR demo to test your own workflow. The resource library includes further implementation and procurement guides.

What else should you know?

Is a flat fee always cheaper than a percentage fee?

No. Compare fee definitions, order values, transaction frequency and the remaining costs using your own business assumptions.

Do all alternatives include clinicians?

No blanket assumption is safe. This shortlist includes clinical infrastructure and a software route; verify staffing in the specific proposal.

What should we do about conflicting FUSE prices?

Ask for a written quote that resolves the plan-card and FAQ discrepancy. Do not select whichever number makes a comparison more persuasive.

Can we keep our current commerce layer?

Some modular routes are designed for that purpose. Confirm the exact integration and who operates its failure paths.

Does TEHR currently offer peptide fulfillment?

Selected TEHR peptide programs are pending and not open for prescribing or fulfillment.

Which sources support this guide?

Public sources reviewed as of 2026-10-22. Vendor statements describe the vendor’s published offering; your contract determines actual scope.

Build around your operation.

Discuss your categories, patient experience and costs with TEHR.